The oral route for drug administration takes up more than 50% of the available drug in the market. Drug-loaded oral thin films have composed drug quantity that is administered via mouth. The composition of drug-loaded oral thin films not only require API but need supporting biocompatible ingredients such as strip forming polymers, plasticizers, sweetening agents and saliva stimulating agents.
Pharmaceutical companies are banking on oral agents to mark their product portfolio as oral consumables are more consumer friendly in terms of using it. By todays standard, drug-loaded oral thin films are a recognized and accepted technology for the total delivery of active pharmaceutical agents for OTC medications and are in the early phase of development for prescription drugs.
Drug-Loaded Oral Thin Films Market: Drivers and Restraints
There are clinical benefits associated with drug-loaded oral thin films that make it a diverse product category, they provide large surface area for dissolution of the required formulation. Rapid absorption rate summed with faster action and biocompatibility makes the drug-loaded oral thin films market more prominent one to cash on.
Though there are clinical differences for the of use drug-loaded oral thin films as high dose of solution cannot be infused into the strip. Hence, examiners have confirmed that the concentration level of active substance can be improved up to 50%. The expensive packaging cost in developing drug-loaded oral thin films is also effecting the production and adoption of such product. These drug-loaded oral thin films are best suited for paediatric and geriatric patients who display a large patient pool and opportunity for other companies.
Major pharmaceutical companies and consumers alike have embraced drug-loaded oral thin films as a more sustainable and positive approach to other traditional over-the-counter medicine forms. Drug-loaded oral thin films offer accurate dosing in a safe and fast environment. Drug-loaded oral thin films have an effective format that is suitable and manageable, without the need of other supporting product.
Know More Details About the Report
Drug-Loaded Oral Thin Films Market: Overview
In North America more than 80 drug-loaded oral thin films brands have been launched since 2003. The drug-loaded oral thin films are marketed through all corners, be it a prescription drug or over the counter drug. The global market for drug-loaded oral thin films is expected to witness a continuous growth over a period due to technological differences.
The market is expected to grow with growing incidence of HIVAN cases, but the drug-loaded oral thin films type could easily expect new technologies with better patient response.Among the drug types, NSAIDs segment is expected to experience a robust growth with range of indications being covered by the formulation.
Drug-Loaded Oral Thin Films Market: Regional Outlook
Geographically, the global drug-loaded oral thin films market is segmented into North America, Latin America, Europe, Asia-Pacific excluding Japan (APEJ), Japan and the Middle East and Africa (MEA). North America is expected to be the dominant regional market for drug-loaded oral thin films owing to presence of key players and developed healthcare infrastructure.
The drug-loaded oral thin films market in Asia Pacific excluding Japan is expected to grow at a significant CAGR due to expansion of offerings by the key providers and rise in generic medicines. Europe is expected to have a large share in the global drug-loaded oral thin films market throughout the forecast period due to its quality healthcare facilities and modern outlook for drug-loaded oral thin films use.
Avail customized purchase options for your needs
Drug-Loaded Oral Thin Films Market: Key Players
The global market for drug-loaded oral thin films is highly fragmented. Examples of some of the key players operating in the global drug-loaded oral thin films market are Labtec, BioAlliance Pharma, MonoSol Rx, Hughes Medical Corp., Paladin Labs, ZIM Laboratories Limited, Indivior plc, Aquestive Therapeutics, Inc., Sumitomo Dainippon Pharma Co., Ltd., IntelGenx Corp., Pfizer, Inc., Novartis AG, Allergan plc, and NAL Pharma.
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
The report covers exhaustive analysis on:
- Market Segments
- Market Dynamics
- Market Size
- Supply & Demand
- Current Trends/Issues/Challenges
- Competition & Companies involved
- Value Chain
An Adaptive Approach to Modern-day Research Needs
Regional analysis includes
- North America
- Latin America
- Rest of LatAm
- EU – 4 (Germany, France, Italy, Spain)
- BENELUX (Belgium, Netherlands, Luxemburg)
- NORDIC (Norway, Denmark, Iceland, Sweden)
- Eastern Europe (Poland, Ukraine, Czech Rep. etc.)
- Rest of Europe
- CIS & Russia
- Greater China
- ASEAN Countries
- Rest of APEJ
- Middle East & Africa
- GCC Countries
- South Africa
- Rest of MEA
- Detailed overview of parent market
- Changing market dynamics in the industry
- In-depth market segmentation
- Historical, current and projected market size in terms of volume and value
- Recent industry trends and developments
- Competitive landscape
- Strategies of key players and products offered
- Potential and niche segments, geographical regions exhibiting promising growth
- A neutral perspective on market performance
- Must-have information for market players to sustain and enhance their market footprint.
Have a report related query? Speak to us directly
Drug-Loaded Oral Thin Films Market: Segmentation
Tentatively, the global drug-loaded oral thin films market can be segmented on the basis of drug type, distribution channel and geography.
Based on Drug Type, the global drug-loaded oral thin films market is segmented as:
Based on Distribution Channel, the global drug-loaded oral thin films market is segmented as:
- Hospital pharmacy
- Retail pharmacy
Need an Exclusive Report for your Unique Requirement?
- Our Clients -
- Evaluate How Fact.MR's Report Can Help. -
Is the market research conducted by Fact.MR?
Yes, the report has been compiled by expert analysts of Fact.MR, through a combination of primary and secondary research. To know more about how the research was conducted, you can speak to a research analyst.
What research methodology is followed by Fact.MR?
Fact.MR follows a methodology that encompasses the demand-side assessment of the market, and triangulates the same through a supply-side analysis. This methodology is based on the use of standard market structure, methods, and definitions.
What are the sources of secondary research?
Fact.MR conducts extensive secondary research through proprietary databases, paid databases, and information available in the public domain. We refer to industry associations, company press releases, annual reports, investor presentations, and research papers. More information about desk research is available upon request.
Who are the respondents for primary research?
Fact.MR speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, and industry experts. For a full list of primary respondents, please reach out to us.
Is a sample of this report available for evaluation?
Yes, you can request a sample, and it will be sent to you through an email.